-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, C5D1Sa5j5pCKJsijHYHgE8Iy49vTWIXbib0LfL1N47GsNlymoAnKeh+Kk6Sc4je8 rYYEqDIrigLCOBaaqgQAAg== 0000894579-96-000100.txt : 19961024 0000894579-96-000100.hdr.sgml : 19961024 ACCESSION NUMBER: 0000894579-96-000100 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19961023 SROS: NONE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MORGENS WATERFALL VINTIADIS & CO INC CENTRAL INDEX KEY: 0001016150 STANDARD INDUSTRIAL CLASSIFICATION: AIRCRAFT [3721] IRS NUMBER: 132674766 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-46923 FILM NUMBER: 96646712 BUSINESS ADDRESS: STREET 1: 10 EAST 50TH STREET STREET 2: 10 EAST 50TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2127050500 MAIL ADDRESS: STREET 1: 10 EAST 50TH ST CITY: NEW YORK STATE: NY ZIP: 10022 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: DECHERT PRICE & RHOADS/ NY/ FA CENTRAL INDEX KEY: 0000894579 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] STATE OF INCORPORATION: DC FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: 477 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2026263352 MAIL ADDRESS: STREET 1: 477 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: DECHERT PRICE & RHOADS/ NY/ FA DATE OF NAME CHANGE: 19950407 SC 13D 1 HEMASURE INC. 13D --------------------------------- QMB APPROVAL --------------------------------- QMB Number: 3235-0145 Expires: October 31, 1994 Estimated average burden hours per form............14.90 --------------------------------- SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4)* Hemasure Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, par value $.0001 per share - -------------------------------------------------------------------------------- (Title of Class of Securities) 423504109 --------------------------------- (CUSIP Number) Edwin H. Morgens, 10 East 50th Street, New York, NY 10022, (212) 705-0500 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) October 16, 1996 --------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box |_|. Check the following box if a fee is being paid with the statement [X]. (A fee is not required only if the reporting person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7.) Note: Six copies of this statement, including all exhibits, should be filed with the Commission. See Rule 13d-1(a) for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 17 Pages Exhibit Index Appears on Page 17 SCHEDULE 13D CUSIP No. 423504109 Page 2 of 17 Pages _________________________________________________________________ 1) NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Phoenix Partners 13-6272912 _________________________________________________________________ 2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [x] _________________________________________________________________ 3) SEC USE ONLY _________________________________________________________________ 4) SOURCE OF FUNDS* WC _________________________________________________________________ 5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ] _________________________________________________________________ 6) CITIZENSHIP OR PLACE OF ORGANIZATION New York State _________________________________________________________________ NUMBER 7) SOLE VOTING POWER OF 211,900 - See Response to Item 5 SHARES _______________________________________________ BENEFICIALLY 8) SHARED VOTING POWER OWNED BY 0 EACH _______________________________________________ REPORTING 9) SOLE DISPOSITIVE POWER PERSON 211,900 - See Response to Item 5 WITH _______________________________________________ 10) SHARED DISPOSITIVE POWER 0 _________________________________________________________________ 11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 211,900 _________________________________________________________________ 12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ] _________________________________________________________________ 13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 2.6% _________________________________________________________________ 14) TYPE OF REPORTING PERSON* PN _________________________________________________________________ *SEE INSTRUCTIONS BEFORE FILLING OUT! SCHEDULE 13D CUSIP No. 423504109 Page 3 of 17 Pages _________________________________________________________________ 1) NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Betje Partners 13-3118883 _________________________________________________________________ 2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [x] _________________________________________________________________ 3) SEC USE ONLY _________________________________________________________________ 4) SOURCE OF FUNDS* WC _________________________________________________________________ 5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ] _________________________________________________________________ 6) CITIZENSHIP OR PLACE OF ORGANIZATION New York State _________________________________________________________________ NUMBER 7) SOLE VOTING POWER OF 73,500 - See Response to Item 5 SHARES _______________________________________________ BENEFICIALLY 8) SHARED VOTING POWER OWNED BY 0 EACH _______________________________________________ REPORTING 9) SOLE DISPOSITIVE POWER PERSON 73,500 - See Response to Item 5 WITH _______________________________________________ 10) SHARED DISPOSITIVE POWER 0 _________________________________________________________________ 11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 73,500 _________________________________________________________________ 12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ] _________________________________________________________________ 13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0.9% _________________________________________________________________ 14) TYPE OF REPORTING PERSON* PN _________________________________________________________________ *SEE INSTRUCTIONS BEFORE FILLING OUT! SCHEDULE 13D CUSIP No. 423504109 Page 4 of 17 Pages _________________________________________________________________ 1) NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Morgens Waterfall Vintiadis Investments N.V. None _________________________________________________________________ 2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [x] _________________________________________________________________ 3) SEC USE ONLY _________________________________________________________________ 4) SOURCE OF FUNDS* WC _________________________________________________________________ 5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ] _________________________________________________________________ 6) CITIZENSHIP OR PLACE OF ORGANIZATION Netherlands Antilles _________________________________________________________________ NUMBER 7) SOLE VOTING POWER OF 131,100 - See Response to Item 5 SHARES _______________________________________________ BENEFICIALLY 8) SHARED VOTING POWER OWNED BY 0 EACH _______________________________________________ REPORTING 9) SOLE DISPOSITIVE POWER PERSON 131,100 - See Response to Item 5 WITH _______________________________________________ 10) SHARED DISPOSITIVE POWER 0 _________________________________________________________________ 11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 131,100 _________________________________________________________________ 12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ] _________________________________________________________________ 13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 1.6% _________________________________________________________________ 14) TYPE OF REPORTING PERSON* CO _________________________________________________________________ *SEE INSTRUCTIONS BEFORE FILLING OUT! SCHEDULE 13D CUSIP No. 423504109 Page 5 of 17 Pages _________________________________________________________________ 1) NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON MWV Employee Retirement Plan Group Trust 13-3845507 _________________________________________________________________ 2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [x] _________________________________________________________________ 3) SEC USE ONLY _________________________________________________________________ 4) SOURCE OF FUNDS* WC _________________________________________________________________ 5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ] _________________________________________________________________ 6) CITIZENSHIP OR PLACE OF ORGANIZATION New York State _________________________________________________________________ NUMBER 7) SOLE VOTING POWER OF 21,000 - See Response to Item 5 SHARES _______________________________________________ BENEFICIALLY 8) SHARED VOTING POWER OWNED BY 0 EACH _______________________________________________ REPORTING 9) SOLE DISPOSITIVE POWER PERSON 21,000 - See Response to Item 5 WITH _______________________________________________ 10) SHARED DISPOSITIVE POWER 0 _________________________________________________________________ 11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 21,000 _________________________________________________________________ 12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ] _________________________________________________________________ 13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0.3% _________________________________________________________________ 14) TYPE OF REPORTING PERSON* EP _________________________________________________________________ *SEE INSTRUCTIONS BEFORE FILLING OUT! SCHEDULE 13D CUSIP No. 423504109 Page 6 of 17 Pages _________________________________________________________________ 1) NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Phaeton International N.V. None _________________________________________________________________ 2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [x] _________________________________________________________________ 3) SEC USE ONLY _________________________________________________________________ 4) SOURCE OF FUNDS* AF _________________________________________________________________ 5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ] _________________________________________________________________ 6) CITIZENSHIP OR PLACE OF ORGANIZATION Netherlands Antilles _________________________________________________________________ NUMBER 7) SOLE VOTING POWER OF 0 - See Response to Item 5 SHARES _______________________________________________ BENEFICIALLY 8) SHARED VOTING POWER OWNED BY 0 EACH _______________________________________________ REPORTING 9) SOLE DISPOSITIVE POWER PERSON 0 - See Response to Item 5 WITH _______________________________________________ 10) SHARED DISPOSITIVE POWER 0 _________________________________________________________________ 11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 131,100 _________________________________________________________________ 12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ] _________________________________________________________________ 13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 1.6% _________________________________________________________________ 14) TYPE OF REPORTING PERSON* CO _________________________________________________________________ *SEE INSTRUCTIONS BEFORE FILLING OUT! SCHEDULE 13D CUSIP No. 423504109 Page 7 of 17 Pages _________________________________________________________________ 1) NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Morgens, Waterfall, Vintiadis & Company, Inc. 13-2674766 _________________________________________________________________ 2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [x] _________________________________________________________________ 3) SEC USE ONLY _________________________________________________________________ 4) SOURCE OF FUNDS* AF _________________________________________________________________ 5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ] _________________________________________________________________ 6) CITIZENSHIP OR PLACE OF ORGANIZATION New York State _________________________________________________________________ NUMBER 7) SOLE VOTING POWER OF 0 - See Response to Item 5 SHARES _______________________________________________ BENEFICIALLY 8) SHARED VOTING POWER OWNED BY 0 EACH _______________________________________________ REPORTING 9) SOLE DISPOSITIVE POWER PERSON 0 - See Response to Item 5 WITH _______________________________________________ 10) SHARED DISPOSITIVE POWER 0 _________________________________________________________________ 11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 204,600 _________________________________________________________________ 12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ] _________________________________________________________________ 13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 2.5% _________________________________________________________________ 14) TYPE OF REPORTING PERSON* CO _________________________________________________________________ *SEE INSTRUCTIONS BEFORE FILLING OUT! SCHEDULE 13D CUSIP No. 423504109 Page 8 of 17 Pages _________________________________________________________________ 1) NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Edwin H. Morgens ###-##-#### _________________________________________________________________ 2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [x] _________________________________________________________________ 3) SEC USE ONLY _________________________________________________________________ 4) SOURCE OF FUNDS* AF _________________________________________________________________ 5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ] _________________________________________________________________ 6) CITIZENSHIP OR PLACE OF ORGANIZATION United States _________________________________________________________________ NUMBER 7) SOLE VOTING POWER OF 0 - See Response to Item 5 SHARES _______________________________________________ BENEFICIALLY 8) SHARED VOTING POWER OWNED BY 0 EACH _______________________________________________ REPORTING 9) SOLE DISPOSITIVE POWER PERSON 0 - See Response to Item 5 WITH _______________________________________________ 10) SHARED DISPOSITIVE POWER 0 _________________________________________________________________ 11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 437,500 _________________________________________________________________ 12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ] _________________________________________________________________ 13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 5.4% _________________________________________________________________ 14) TYPE OF REPORTING PERSON* IN _________________________________________________________________ *SEE INSTRUCTIONS BEFORE FILLING OUT! SCHEDULE 13D CUSIP No. 423504109 Page 9 of 17 Pages _________________________________________________________________ 1) NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Bruce Waterfall ###-##-#### _________________________________________________________________ 2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [x] _________________________________________________________________ 3) SEC USE ONLY _________________________________________________________________ 4) SOURCE OF FUNDS* AF _________________________________________________________________ 5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ] _________________________________________________________________ 6) CITIZENSHIP OR PLACE OF ORGANIZATION United States _________________________________________________________________ NUMBER 7) SOLE VOTING POWER OF 0 - See Response to Item 5 SHARES _______________________________________________ BENEFICIALLY 8) SHARED VOTING POWER OWNED BY 0 EACH _______________________________________________ REPORTING 9) SOLE DISPOSITIVE POWER PERSON 0 - See Response to Item 5 WITH _______________________________________________ 10) SHARED DISPOSITIVE POWER 0 _________________________________________________________________ 11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 416,500 _________________________________________________________________ 12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ] _________________________________________________________________ 13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 5.2% _________________________________________________________________ 14) TYPE OF REPORTING PERSON* IN _________________________________________________________________ *SEE INSTRUCTIONS BEFORE FILLING OUT! Hemasure Inc. Page 10 of 17 Pages Schedule 13D October 23, 1996 Item 1. Security and Issuer. - ------- -------------------- This statement on Schedule 13D ("Statement") relates to the common stock, par value $.01 per share ("Common Stock"), of Hemasure Inc. (the "Issuer"). The principal executive offices of the Issuer are located at 140 Locke Drive, Marlborough, Massachusetts 01752. Item 2. Identity and Background. This Statement is filed jointly by (a) Phoenix Partners ("Phoenix"), (b) Betje Partners ("Betje"), (c) Morgens Waterfall Vintiadis Investments N.V. ("MWV"), (d) MWV Employee Retirement Plan Group Trust ("MWV Plan"), (e) Phaeton International N.V. ("Phaeton"), (f) Morgens, Waterfall, Vintiadis & Company, Inc. ("Morgens Waterfall"), (g) Edwin H. Morgens ("Morgens") and (h) Bruce Waterfall ("Waterfall" and together with the persons listed in paragraphs (a) through (h), the "Reporting Persons"). MWV is a subsidiary of Phaeton. Phaeton is a controlling person of MWV by virtue of its ownership of 100% of the outstanding shares of MWV. Phaeton and MWV are Netherlands Antilles limited liability companies having their principal offices at 6 John B. Gorsiraweg, Willemstad, Curacao, Netherlands Antilles. The principal business of MWV is to invest in securities of United States issuers. Phaeton is a holding company which invests in MWV and companies with similar objectives. The sole Managing Director of Phaeton and MWV is Offshore Management Company N.V. ("Offshore"), a Netherlands Antilles limited liability company having its principal office at 6 John B. Gorsiraweg, Willemstad, Curacao, Netherlands Antilles. The principal business of Offshore is to act as Managing Director of corporations domiciled in the Netherlands Antilles, and in that capacity to provide local management, administrative, clerical and accounting services similar to those which it provides to Phaeton and MWV. Phaeton and MWV do not have any officers other than Offshore. Phaeton and MWV have the following Board of Directors: Name Address ---- ------- Halvor Astrup Fearnley Group A/S 35-38 Portman Square London W1HOEU, England Hemasure Inc. Page 11 of 17 Pages Schedule 13D October 23, 1996 Dr. M. Colyer Crum Harvard Business School Cambridge, Massachusetts Bassam Aburdene Capital Trust Ltd. 49 Mount Street London WIY5RE, England Fred Arthur Rank Packard Center 45 45 London Wall London EC2, England Mr. Astrup, a citizen of Norway, is Vice Chairman of Fearnley Group and Chairman of Fearnley Finance Ltd., companies principally engaged in project development in the international shipping industry. Dr. Crum, a U.S. citizen, is a professor at the Harvard Business School, where he holds the James R. Williston Chair of Investment Management. Mr. Aburdene, a U.S. citizen, is a Managing Partner of Capital Trust Limited, a London-based financial services company which is jointly owned by United States and Middle Eastern institutions and investors. Mr. Packard, a British citizen, is a partner of Banco de Investimentos Garantia, a leading Brazilian investment bank. Phoenix and Betje are New York limited partnerships having their principal address at 10 East 50th Street, New York, New York 10022. The principal business of Phoenix and Betje is to invest in securities of United States issuers. Morgens and Waterfall are the managing members of MW Management LLC, which is the general partner of Phoenix. All of the information concerning Morgens and Waterfall is set forth below. Mr. Zanvyl Krieger is the general partner of Betje. The business address of Mr. Krieger is c/o Weinberg and Green, 100 South Charles Street, Baltimore, Maryland 21201. Mr. Krieger's principal occupation is a private investor. MWV Plan is a trust established in 1994 for the benefit of the employees of Morgens Waterfall. The trustees of the MWV Plan are David Ericson, Dan Levinson, Morgens, John Raphael and Stephan Yost, all of whom are employees of Morgens Waterfall. MWV Plan's principal address is 10 East 50th Street, New York, New York 10022. All of the relevant information concerning Morgens Waterfall and Morgens is set forth below. Morgens Waterfall is a New York corporation having its principal address at 10 East 50th Street, New York, New York 10022. Hemasure Inc. Page 12 of 17 Pages Schedule 13D October 23, 1996 The business of Morgens Waterfall is rendering of financial services and as such it provides discretionary investment advisory services pursuant to contracts with MWV and Betje. Under the rules promulgated by the Securities and Exchange Commission, Morgens Waterfall and its principals may be considered "beneficial owners" of securities acquired by MWV and Betje as a result of its advisory relationship to MWV and Betje. Morgens is the Chairman of the Board of Directors and the Secretary of Morgens Waterfall. Waterfall is the President and Assistant Secretary of Morgens Waterfall and is also a Director. The primary occupations of Morgens and Waterfall are to act as the principals in the business of Morgens Waterfall. The business address of Morgens and Waterfall, each of whom is a United States citizen, is at the office of Morgens Waterfall at 10 East 50th Street, New York, New York 10022. Morgens Waterfall has no other officers and directors. During the past five years, none of the persons described in this Item 2 have been convicted in a criminal proceeding. None of such persons is, and during the past five years none has been, subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws, or finding any violations with respect to such laws. Item 3. Source and Amount of Funds or Other Consideration. - ------- -------------------------------------------------- The Common Stock held by the Reporting Persons was purchased in the over-the-counter market through brokerage transactions. The source of the payments by Phoenix, Betje, MWV and MWV Plan was working capital, and no part of the purchase price was represented by funds or other consideration specially borrowed or otherwise specifically obtained for the purpose of acquiring, holding, trading or voting the securities. Item 4. Purpose of Transaction. - ------- ----------------------- The Common Stock was acquired by Phoenix, Betje, MWV and MWV Plan in the over-the-counter market through brokerage transactions in the ordinary course of business, solely as an investment. The Reporting Persons have no present plans or proposals that relate to or would result in any of the actions enumerated in Item 4 of Schedule 13D, although they reserve the right to buy additional securities of the Issuer or sell securities of the Issuer from time to time. Hemasure Inc. Page 13 of 17 Pages Schedule 13D October 23, 1996 Item 5. Interest in Securities of the Issuer. (a) and (b) The following is the amount of Common Stock that is is beneficially owned by each Reporting Person: Aggregate Percentage Name # of Shares of Class ---- ----------- -------- Phoenix 211,900 2.6 Betje 73,500 0.9 MWV 131,100 1.6 MWV Plan 21,000 0.3 ------ ---- Total 437,500 5.4 Phaeton does not directly own any of the Common Stock. Phaeton may be deemed to indirectly beneficially own 131,100 shares of Common Stock by virtue of its 100% ownership of MWV. Morgens Waterfall does not directly own any of the Common Stock. Morgens Waterfall may be deemed to indirectly beneficially own 204,600 shares of Common Stock by virtue of contracts with MWV (131,100 shares) and Betje (73,500 shares) pursuant to which Morgens Waterfall provides discretionary investment advisory services. Morgens does not directly own any of the Common Stock. Morgens may be deemed to indirectly beneficially own 437,500 shares of Common Stock by virtue of his positions as Chairman of the Board of Directors and Secretary of Morgens Waterfall (204,600 shares); as a managing member of MW Management LLC, which is the general partner of Phoenix (211,900 shares); and as trustee of MWV Plan (21,000 shares). Waterfall does not directly own any of the Common Stock. Waterfall may be deemed to indirectly beneficially own 416,500 shares of Common Stock by virtue of his positions as President, Assistant Secretary and a Director of Morgens Waterfall (204,600 shares) and as a managing member of MW Management LLC, which is the general partner of Phoenix (211,900 shares). Each Reporting Person hereby disclaims that it has any beneficial interest in the securities owned, directly or indirectly, by any other entity. The following is a list of all transactions involving the Common Stock during the past 60 days by any of the Reporting Persons: Hemasure Inc. Page 14 of 17 Pages Schedule 13D October 23, 1996 No. of Shares Price/ Name Date Sold/Purchased Share - ---- ---- -------------- ----- Phoenix 9/18/96 12,000 sold $10.875 10/04/96 22,300 purchased 9.25 10/15/96 47,900 purchased 8.50 10/16/96 30,700 purchased 8.50 10/17/96 2,500 purchased 8.50 Betje 9/18/96 900 sold $10.875 10/04/96 7,600 purchased 9.25 10/15/96 16,100 purchased 8.50 10/16/96 10,500 purchased 8.50 10/17/96 900 purchased 8.50 MWV 9/18/96 2,000 sold $10.875 10/04/96 13,600 purchased 9.25 10/15/96 29,000 purchased 8.50 10/16/96 18,800 purchased 8.50 10/16/9 1,600 purchased 8.50 MWV Plan 10/15/96 7,000 purchased $ 8.50 (d) Except as set forth above, no other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Common Stock. (e) Not applicable. Item 6. Contracts, Arrangements, Understandings or Relationships with - ------- Respect to the Securities of the Issuer. Except to the extent described in Items 2 and 5, none of the persons identified in Item 2 is a party to any contract, arrangement, understanding or relationship with respect to any securities of the Issuer. Hemasure Inc. Page 15 of 17 Pages Schedule 13D October 23, 1996 Item 7. Material to be Filed as Exhibits. EXHIBIT A Power of Attorney, dated December 15, 1993 granted to Messrs. Morgens and Waterfall by the following parties: Mr. Bruce Waterfall; Phoenix Partners; Morgens Waterfall Income Partners; Betje Partners; Phaeton International N.V.; Morgens, Waterfall, Vintiadis Investments N.V.; The Common Fund for Non-Profit Organizations; Morgens Waterfall Vintiadis & Company, Inc.; Restart Partners, L.P.; Restart Partners II, L.P.; Restart Partners III, L.P.; Restart Partners IV, L.P.; Morgens Waterfall, Vintiadis & Co., Inc. Employees' Profit Sharing Plan; and Mr. Edwin Morgens, for the specific purpose of executing on their behalf any Schedule 13Ds and amendments thereto for filing with the Securities and Exchange Commission pursuant to the requirements of Rule 13d-1(f) (incorporated by reference to Exhibit A of Amendment No. 2 to Schedule 13D filed on December 22, 1993 by Phoenix Partners; Betje Partners; Phaeton International N.V.; Morgens, Waterfall, Vintiadis Investments N.V.; Morgens Waterfall Vintiadis & Company, Inc.; Edwin H. Morgens; and Bruce Waterfall with respect to the common stock, par value $.01 per share, of Sudbury, Inc.). EXHIBIT B Power of Attorney, dated as of June 20, 1994 granted to Messrs. Morgens and Waterfall by Morgens Waterfall Overseas Partners, for the specific purpose of executing on its behalf any Schedule 13Ds and amendments thereto for filing with the Securities and Exchange Commission pursuant to the requirements of Rule 13d-1(f) (incorporated by reference to Exhibit B of Schedule 13D filed on June 23, 1994 by Morgens Waterfall Overseas Partners; Morgens Waterfall Income Partners; Morgens Waterfall, Vintiadis & Co., Inc.; Restart Partners, L.P.; Restart Partners II, L.P.; Restart Partners III, L.P.; Restart Partners IV, L.P.; Morgens Waterfall, Vintiadis & Co., Inc. Employees' Profit Sharing Plan; The Common Fund for Non-Profit Organizations; Edwin H. Morgens; and Bruce Waterfall with respect to the common stock, par value $1.00 per share, of Best Products Co., Inc.). Hemasure Inc. Page 16 of 17 Pages Schedule 13D October 23, 1996 SIGNATURES After reasonable inquiry and to the best knowledge and belief of each of the Reporting Persons, each such person or entity certifies that the information set forth in this statement is true, complete and correct and agrees that this statement is filed on behalf of each of them. The Reporting Persons listed herein Dated: October 23, 1996 By: /s/ Bruce Waterfall -------------------------------- Bruce Waterfall, as attorney-in- fact for each of the Reporting Persons Hemasure Inc. Page 17 of 17 Pages Schedule 13D October 23, 1996 EXHIBIT INDEX Page No. --------- Exhibit A Power of Attorney Incorporated by Reference Exhibit B Power of Attorney Incorporated by Reference -----END PRIVACY-ENHANCED MESSAGE-----